320 related articles for article (PubMed ID: 21637285)
1. The emerging role of hypoxia, HIF-1 and HIF-2 in multiple myeloma.
Martin SK; Diamond P; Gronthos S; Peet DJ; Zannettino AC
Leukemia; 2011 Oct; 25(10):1533-42. PubMed ID: 21637285
[TBL] [Abstract][Full Text] [Related]
2. Regulation of hypoxia inducible factors (HIF) in hypoxia and normoxia during placental development.
Patel J; Landers K; Mortimer RH; Richard K
Placenta; 2010 Nov; 31(11):951-7. PubMed ID: 20869770
[TBL] [Abstract][Full Text] [Related]
3. [Metastasis and hypoxia-inducible factor].
Kobayashi M; Nakagawa K
Gan To Kagaku Ryoho; 2010 Nov; 37(11):2047-51. PubMed ID: 21084801
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic targeting of hypoxia and hypoxia-inducible factor 1 alpha in multiple myeloma.
Borsi E; Terragna C; Brioli A; Tacchetti P; Martello M; Cavo M
Transl Res; 2015 Jun; 165(6):641-50. PubMed ID: 25553605
[TBL] [Abstract][Full Text] [Related]
5. Direct transcriptional up-regulation of cyclooxygenase-2 by hypoxia-inducible factor (HIF)-1 promotes colorectal tumor cell survival and enhances HIF-1 transcriptional activity during hypoxia.
Kaidi A; Qualtrough D; Williams AC; Paraskeva C
Cancer Res; 2006 Jul; 66(13):6683-91. PubMed ID: 16818642
[TBL] [Abstract][Full Text] [Related]
6. Hypoxia-inducible factor-2alpha correlates to distant recurrence and poor outcome in invasive breast cancer.
Helczynska K; Larsson AM; Holmquist Mengelbier L; Bridges E; Fredlund E; Borgquist S; Landberg G; Påhlman S; Jirström K
Cancer Res; 2008 Nov; 68(22):9212-20. PubMed ID: 19010893
[TBL] [Abstract][Full Text] [Related]
7. Tumour hypoxia, hypoxia signaling pathways and hypoxia inducible factor expression in human cancer.
Giatromanolaki A; Harris AL
Anticancer Res; 2001; 21(6B):4317-24. PubMed ID: 11908686
[TBL] [Abstract][Full Text] [Related]
8. Impact of hypoxia on the pathogenesis and therapy resistance in multiple myeloma.
Ikeda S; Tagawa H
Cancer Sci; 2021 Oct; 112(10):3995-4004. PubMed ID: 34310776
[TBL] [Abstract][Full Text] [Related]
9. Hypoxia-inducible factor is expressed in giant cell tumour of bone and mediates paracrine effects of hypoxia on monocyte-osteoclast differentiation via induction of VEGF.
Knowles HJ; Athanasou NA
J Pathol; 2008 May; 215(1):56-66. PubMed ID: 18283716
[TBL] [Abstract][Full Text] [Related]
10. Prolyl hydroxylases 2 and 3 act in gliomas as protective negative feedback regulators of hypoxia-inducible factors.
Henze AT; Riedel J; Diem T; Wenner J; Flamme I; Pouyseggur J; Plate KH; Acker T
Cancer Res; 2010 Jan; 70(1):357-66. PubMed ID: 20028863
[TBL] [Abstract][Full Text] [Related]
11. Hypoxia and hypoxia-inducible factor-1 expression enhance osteolytic bone metastases of breast cancer.
Hiraga T; Kizaka-Kondoh S; Hirota K; Hiraoka M; Yoneda T
Cancer Res; 2007 May; 67(9):4157-63. PubMed ID: 17483326
[TBL] [Abstract][Full Text] [Related]
12. Hypoxic regulation of PFKFB-3 and PFKFB-4 gene expression in gastric and pancreatic cancer cell lines and expression of PFKFB genes in gastric cancers.
Bobarykina AY; Minchenko DO; Opentanova IL; Moenner M; Caro J; Esumi H; Minchenko OH
Acta Biochim Pol; 2006; 53(4):789-99. PubMed ID: 17143338
[TBL] [Abstract][Full Text] [Related]
13. The role of the hypoxia-inducible factor in tumor metabolism growth and invasion.
Brahimi-Horn C; Pouysségur J
Bull Cancer; 2006 Aug; 93(8):E73-80. PubMed ID: 16935775
[TBL] [Abstract][Full Text] [Related]
14. Relation of vascular endothelial growth factor production to expression and regulation of hypoxia-inducible factor-1 alpha and hypoxia-inducible factor-2 alpha in human bladder tumors and cell lines.
Jones A; Fujiyama C; Blanche C; Moore JW; Fuggle S; Cranston D; Bicknell R; Harris AL
Clin Cancer Res; 2001 May; 7(5):1263-72. PubMed ID: 11350893
[TBL] [Abstract][Full Text] [Related]
15. A DNA-binding Molecule Targeting the Adaptive Hypoxic Response in Multiple Myeloma Has Potent Antitumor Activity.
Mysore VS; Szablowski J; Dervan PB; Frost PJ
Mol Cancer Res; 2016 Mar; 14(3):253-66. PubMed ID: 26801054
[TBL] [Abstract][Full Text] [Related]
16. HIF-1α inhibition blocks the cross talk between multiple myeloma plasma cells and tumor microenvironment.
Borsi E; Perrone G; Terragna C; Martello M; Zamagni E; Tacchetti P; Pantani L; Brioli A; Dico AF; Zannetti BA; Rocchi S; Cavo M
Exp Cell Res; 2014 Nov; 328(2):444-55. PubMed ID: 25257607
[TBL] [Abstract][Full Text] [Related]
17. Hematopoietic progenitor cell mobilization results in hypoxia with increased hypoxia-inducible transcription factor-1 alpha and vascular endothelial growth factor A in bone marrow.
Lévesque JP; Winkler IG; Hendy J; Williams B; Helwani F; Barbier V; Nowlan B; Nilsson SK
Stem Cells; 2007 Aug; 25(8):1954-65. PubMed ID: 17478585
[TBL] [Abstract][Full Text] [Related]
18. Cellular oxygen sensing need in CNS function: physiological and pathological implications.
Acker T; Acker H
J Exp Biol; 2004 Aug; 207(Pt 18):3171-88. PubMed ID: 15299039
[TBL] [Abstract][Full Text] [Related]
19. Hypoxia-inducible factors and hypoxic cell death in tumour physiology.
Bacon AL; Harris AL
Ann Med; 2004; 36(7):530-9. PubMed ID: 15513303
[TBL] [Abstract][Full Text] [Related]
20. Predominant role of hypoxia-inducible transcription factor (Hif)-1alpha versus Hif-2alpha in regulation of the transcriptional response to hypoxia.
Sowter HM; Raval RR; Moore JW; Ratcliffe PJ; Harris AL
Cancer Res; 2003 Oct; 63(19):6130-4. PubMed ID: 14559790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
